Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study.

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known by brand names Ozempic and Wegovy, has the ability to counter metabolic dysfunction-associated steatohepatitis, or MASH, liver disease and some of its risk factors.

MASH is characterized by inflammation and scarring caused........

© The Hill